A Real-time and Computerized Sonographic Reporting System in Predicting Malignant Cervical Lymphadenopathy

This study has been completed.
Sponsor:
Information provided by:
Far Eastern Memorial Hospital
ClinicalTrials.gov Identifier:
NCT01130402
First received: May 24, 2010
Last updated: May 25, 2010
Last verified: April 2009
  Purpose

The investigaotors want to establish a real-time and computerized score reporting system based on the significant predictors of the measured sonographic parameters and demographic data.


Condition
Lymphadenopathy

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: A Real-time and Computerized Sonographic Scoring System for Predicting Malignant Cervical Lymphadenopathy

Further study details as provided by Far Eastern Memorial Hospital:

Primary Outcome Measures:
  • The final diagnoses of lymph nodes were made by US-FNA cytological studies, pathologic results of the biopsy specimens, or at least 3 months of negative follow-up observations. [ Time Frame: 3 months ] [ Designated as safety issue: No ]

Enrollment: 189
Study Start Date: June 2009
Study Completion Date: September 2009
Groups/Cohorts
Neck masses
Patients with previously untreated neck masses

Detailed Description:

One hundred eight patients with neck lymphadenopathy, receiving ultrasonography and ultrasound-guided fine-needle aspiration (US-FNA), were used to construct a predictive model. This model was validated by another independent patient cohort.

  Eligibility

Ages Eligible for Study:   10 Years to 83 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

patients with previously untreated neck masses were referred for sonographic evaluation and subsequent US-FNA after informed consent was obtained. Demographic data, including age and sex, side, site, and number of lymphadenopathy was collected as well.

Criteria

Inclusion Criteria:

  • Patients with previously untreated neck masses underwent neck US

Exclusion Criteria:

  • The neck mass was not lymph node
  • No US-FNA cytology result
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01130402

Locations
Taiwan
Far Eastern Memorial Hospital
Taipei, Taiwan, 22050
Sponsors and Collaborators
Far Eastern Memorial Hospital
Investigators
Study Director: Li-Jen Liao, MD Department of Otolaryngology, Far Eastern Memorial Hospital, Taipei, Taiwan
  More Information

Additional Information:
Publications:
Responsible Party: Research Ethics Review Committee, Far Eastern Memorial Hospital, Taipei, Taiwan
ClinicalTrials.gov Identifier: NCT01130402     History of Changes
Other Study ID Numbers: 098026-3
Study First Received: May 24, 2010
Last Updated: May 25, 2010
Health Authority: Taiwan: Institutional Review Board

Keywords provided by Far Eastern Memorial Hospital:
age
lymphadenopathy
fine needle aspiration
sonography

Additional relevant MeSH terms:
Lymphatic Diseases

ClinicalTrials.gov processed this record on August 28, 2014